The Trump administration has cancelled a $258 million programme that was working to develop vaccines against HIV, dealing a major blow to efforts to find a cure for the disease that causes AIDS.
The decision affects research teams at two leading American universities who were making important progress in the fight against HIV. The Trump administration has dealt a sharp blow to work on H.I.V. vaccines, terminating a $258 million program whose work was instrumental to the search for a vaccine.
Government health officials broke the news on Friday to the programme leaders at Duke University and the Scripps Research Institute. Officials from the H.I.V. division of the National Institutes of Health delivered the news on Friday to the program’s two leaders, at Duke University and the Scripps Research Institute.